Eying 3 approvals in 2 years, Ocugen’s CEO wants to bring gene therapy to the masses

Fuente: FierceBiotech
Many gene therapy outfits focus on technical advances, Ocugen CEO Shankar Musunuri, Ph.D., said, meaning they miss out on broader commercial success.
Volver